Professional
Added to YB: 2024-01-29
Pitch date: 2024-01-29
VTRS [bullish]
Viatris Inc.
+47.63%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
Market Cap
$18.2B
Pitch Price
$10.82
Price Target
21.66 (+36%)
Dividend
3.04%
EV/EBITDA
7.70
P/E
-5.04
EV/Sales
2.25
Sector
Pharmaceuticals
Category
turnaround
Show full summary:
Greenlight Capital new position: Viatris ($VTRS)
$VTRS: New mgmt, generic drug pricing stabilized, revenue & FCF growing. Simplifying portfolio via divestitures, 50% FCF to be returned via "aggressive" buybacks. Acquired at 4x '24 consensus EPS.
Read full article (1 min)